Last week, the Biotech industry hasn't moved much but Polaris Group is up 11% in that time. As for the longer term, the industry has declined 22% in the last year. Looking forward, earnings are forecast to grow by 108% annually.
Has the Taiwanese Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 26 Mar 2024 | NT$436.3b | NT$20.9b | -NT$10,146,524,000.00 | 52.8x | -43x | 20.9x |
Thu, 22 Feb 2024 | NT$449.6b | NT$19.9b | -NT$9,857,794,000.00 | 39.7x | -45.6x | 22.6x |
Sat, 20 Jan 2024 | NT$449.8b | NT$19.8b | -NT$9,748,146,000.00 | 39.9x | -46.1x | 22.8x |
Mon, 18 Dec 2023 | NT$474.3b | NT$19.9b | -NT$9,737,975,000.00 | 42.5x | -48.7x | 23.9x |
Wed, 15 Nov 2023 | NT$465.9b | NT$19.0b | -NT$10,324,208,000.00 | 47x | -45.1x | 24.5x |
Fri, 13 Oct 2023 | NT$467.2b | NT$18.3b | -NT$10,774,226,000.00 | 46.1x | -43.4x | 25.5x |
Sun, 10 Sep 2023 | NT$487.9b | NT$18.3b | -NT$10,596,353,000.00 | 42.6x | -46x | 26.6x |
Tue, 08 Aug 2023 | NT$467.8b | NT$18.6b | -NT$10,798,870,000.00 | 51.5x | -43.3x | 25.2x |
Thu, 06 Jul 2023 | NT$486.0b | NT$18.7b | -NT$10,709,428,000.00 | 44x | -45.4x | 26x |
Sat, 03 Jun 2023 | NT$493.7b | NT$18.8b | -NT$10,346,471,000.00 | 43.4x | -47.7x | 26.3x |
Mon, 01 May 2023 | NT$515.7b | NT$18.5b | -NT$9,925,325,000.00 | 44.1x | -52x | 27.9x |
Wed, 29 Mar 2023 | NT$500.8b | NT$20.5b | -NT$9,016,573,000.00 | 37.6x | -55.5x | 24.5x |
Fri, 24 Feb 2023 | NT$527.8b | NT$21.8b | -NT$7,840,926,000.00 | 38x | -67.3x | 24.2x |
Sun, 22 Jan 2023 | NT$494.2b | NT$21.8b | -NT$7,778,690,000.00 | 36.2x | -63.5x | 22.7x |
Tue, 20 Dec 2022 | NT$510.1b | NT$21.8b | -NT$7,522,211,000.00 | 37.4x | -67.8x | 23.4x |
Thu, 17 Nov 2022 | NT$504.4b | NT$23.1b | -NT$6,733,048,000.00 | 32.7x | -74.9x | 21.8x |
Sat, 15 Oct 2022 | NT$475.0b | NT$23.1b | -NT$6,633,590,000.00 | 34.7x | -71.6x | 20.6x |
Mon, 12 Sep 2022 | NT$630.8b | NT$23.1b | -NT$6,633,590,000.00 | 44.6x | -95.1x | 27.3x |
Wed, 10 Aug 2022 | NT$558.6b | NT$22.6b | -NT$5,710,103,000.00 | 32.2x | -97.8x | 24.7x |
Fri, 08 Jul 2022 | NT$510.4b | NT$22.5b | -NT$5,642,821,000.00 | 30.4x | -90.5x | 22.6x |
Sun, 05 Jun 2022 | NT$502.1b | NT$22.5b | -NT$5,642,821,000.00 | 32.1x | -89x | 22.3x |
Tue, 03 May 2022 | NT$529.2b | NT$21.6b | -NT$5,790,297,000.00 | 45.2x | -91.4x | 24.6x |
Thu, 31 Mar 2022 | NT$528.2b | NT$19.6b | -NT$4,949,407,000.00 | 29.2x | -106.7x | 27x |
Sat, 26 Feb 2022 | NT$456.8b | NT$17.9b | -NT$5,564,340,000.00 | 24.9x | -82.1x | 25.5x |
Mon, 24 Jan 2022 | NT$428.1b | NT$17.9b | -NT$5,532,702,000.00 | 24.3x | -77.4x | 23.9x |
Wed, 22 Dec 2021 | NT$446.4b | NT$17.9b | -NT$5,579,296,000.00 | 26.9x | -80x | 24.9x |
Fri, 19 Nov 2021 | NT$368.1b | NT$18.2b | -NT$6,360,614,000.00 | 22.5x | -57.9x | 20.2x |
Sun, 17 Oct 2021 | NT$345.2b | NT$15.4b | -NT$7,624,179,000.00 | 19.9x | -45.3x | 22.4x |
Tue, 14 Sep 2021 | NT$384.2b | NT$15.4b | -NT$7,624,179,000.00 | 21.7x | -50.4x | 25x |
Thu, 12 Aug 2021 | NT$394.4b | NT$15.4b | -NT$7,624,179,000.00 | 20.5x | -51.7x | 25.6x |
Mon, 07 Jun 2021 | NT$405.6b | NT$13.7b | -NT$8,453,670,500.00 | 25.9x | -48x | 29.5x |
-48.4x
How does Taiwanese Biotech compare with similar industries?
TW Market | 1.52% | |
Healthcare | 1.71% | |
Biotech | 1.01% | |
Biotech | 1.01% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
6550 Polaris Group | NT$68.50 | 11.6% +NT$5.3b | -30.0% | PS14542.3x | |
6976 Acepodia | NT$28.85 | 10.7% +NT$1.6b | n/a | PE-11.6x | |
4728 Sunmax Biotechnology | NT$224.50 | 6.9% +NT$789.7m | 59.8% | PE19.5x | |
4157 TaiGen Biopharmaceuticals Holdings | NT$15.35 | 5.9% +NT$610.2m | 1.0% | PE80.6x | |
6657 Energenesis BiomedicalLTD | NT$58.30 | 6.8% +NT$281.3m | -8.6% | PS619.2x |